跳至主要内容
临床试验/NCT05097534
NCT05097534已完成不适用

A Comprehensive Community Approach for Diabetes Prevention and Care for a Vulnerable Population in Galveston

The University of Texas Medical Branch, Galveston1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2021年12月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
98
试验地点
1
主要终点
Change from baseline HbA1c

研究概览

简要总结

To improve diabetes self-management outcomes, patients with type 2 diabetes (n=150 - aged 13-84) recruited from St. Vincent Clinic (SVC) and Teen Health Center Inc., Clinics will be randomized using block randomization to receive standard of care or the integrated model. Patients in the intervention arm will be assessed for social and physical needs before being enrolled in a year-long education program (iDSMES). Enrollees will receive dietary counseling, physical and occupational therapy, in addition to other mental, financial and social benefits counseling. The investigators will compare the intervention outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
13 Years 至 84 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 13-84, and
  • Patients diagnosed with type 2 diabetes, and
  • Patients have a BMI equal to or >25 (23, if Asians), and
  • Hemoglobin A1c value equal to or >7%

排除标准

  • Ages <13 or >84
  • Pregnancy. If a subject becomes pregnant, they will advised to discontinue the study.
  • Previous diagnosis of type 1 diabetes
  • Inability to participate for 12-month duration (e.g., Disorders that might compromise survival, planning to relocate outside the geographical coverage of University of Texas Medical Branch (UTMB) clinics
  • Other medical condition or medication administration deemed exclusionary by the study investigators

研究组 & 干预措施

iDSMES

Active Comparator

Eligible study subjects randomized to the intervention arm will receive:

A. Intensive Diabetes Self-Management, Education, and Support (iDSMES). Participants will be enrolled in groups in a virtual or in-person setting with their lifestyle coach, in this one-year educational program B. Services addressing Social Determinants of Health All study subjects will have their data collected at time points around baseline, 6 months and 12 months from consenting including glycemic control, hypertension management, dyslipidemia management, prevention or management of complications, healthcare outcomes, lifestyle change outcomes, patient-centeredness outcomes, Secondary diabetes self-management behaviors, self-efficacy in managing diabetes, diabetes distress, and Morisky Green Levine Medication Adherence Scale.

干预措施: iDSMES (Other)

Standard of Care

Placebo Comparator

Eligible study subjects randomized to the intervention arm will receive standard of care offered to patients with diabetes.

干预措施: Standard of Care (Other)

结局指标

主要结局

Change from baseline HbA1c

时间窗: at 12 months

measurement of hemoglobin A1c (HbA1c %)

Change from baseline HbA1c

时间窗: at 6 months

measurement of hemoglobin A1c (HbA1c %)

次要结局

  • Change from baseline blood pressure(at 12 months)
  • Change from baseline weight(at 12 months)
  • Change from baseline lipid profile(at 12 months)
  • Change from baseline frequency of provider encounter(at 12 months)
  • Change from baseline frequency of feet examination for neuropathy(at 12 months)
  • Change from baseline frequency of urine exam for microalbuminuria(at 12 months)
  • Change from baseline frequency of oral health checkup(at 12 months)
  • Change from baseline frequency of eye fundus examination(at 12 months)
  • Change from baseline patient-centeredness(at 12 months)
  • Change from baseline frequency of emergency care visits for treatment of T2-related issues(at 12 months)
  • Change from baseline frequency of hospitalizations and re-admissions(at 12 months)
  • Participation in iDSMES classes (for those in the intervention arm only)(at 12 months)
  • Lifestyle change outcomes (for those in the intervention arm only)(every session through study completion, an average of 1 year)
  • Change from baseline secondary diabetes self-management behaviors(at 12 months)
  • Change from baseline self-efficacy in managing diabetes(at 12 months)
  • Change from baseline diabetes distress(at 12 months)
  • Change from baseline medication Adherence(at 12 months)
  • Change from baseline weight(at 6 months)
  • Change from baseline blood pressure(at 6 months)
  • Change from baseline lipid profile(at 6 months)
  • Change from baseline frequency of provider encounter(at 6 months)
  • Change from baseline frequency of feet examination for neuropathy(at 6 months)
  • Change from baseline frequency of urine exam for microalbuminuria(at 6 months)
  • Change from baseline frequency of oral health checkup(at 6 months)
  • Change from baseline frequency of eye fundus examination(at 6 months)
  • Change from baseline frequency of emergency care visits for treatment of T2-related issues(at 6 months)
  • Change from baseline frequency of hospitalizations and re-admissions(at 6 months)
  • Change from baseline patient-centeredness(at 6 months)
  • Change from baseline secondary diabetes self-management behaviors(at 6 months)
  • Change from baseline self-efficacy in managing diabetes(at 6 months)
  • Change from baseline diabetes distress(at 6 months)
  • Change from baseline medication Adherence(at 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验